Connect your AI

Profound Medical PROF Intangibles (Net)

Intangibles (Net) at other companies

BioventusBVS

$359.66M-9.1%

Globus MedicalGMED

$720.85M-6.6%

Segments

By geography

CA$129K-39.7%

Other financials

Income statement

Revenue$5.3M+104%

Gross profit$3.8M+107%

Operating income-$8.0M+28.2%

Net income-$7.1M+34.2%

EPS (diluted)$0.19-47.2%

Balance sheet

Cash & equivalents$50.3M+8.3%

Total debt$7.5M+52.8%

Total equity$59.4M+17.0%

Total assets$73.5M+20.7%

Cash flow

Operating cash flow-$8.6M-3.6%

CapEx$44.0K—

Free cash flow-$9.6M—

Valuation

Market cap$241.65M+33.9%

Enterprise value$198.81M+32.5%

P/S12.8×-2.4×

Profitability

Gross margin71.1%+3.4pp

Operating margin-202.6%-51.3pp

Net margin-206.8%-39.0pp

FCF margin-238.4%—

Returns & leverage

Return on equity-70.6%+4.8pp

Debt / equity0.1×0.0×

Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Profound Medical's intangibles (net)?: Profound Medical (PROF) reported intangibles (net) of $129K in Q1 2026.
How has Profound Medical's intangibles (net) changed year-over-year?: Profound Medical's intangibles (net) decreased by 39.7% year-over-year, from $214K to $129K.
What is the long-term trend for Profound Medical's intangibles (net)?: Over 2 years (2023 to 2025), Profound Medical's intangibles (net) has grown at a -46.9% compound annual growth rate (CAGR), from $490K to $138K.
What does intangibles (net) mean?: Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.